LeafNLP Demos
Back to explore

Report #2881580

Received Jan 12, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
28 yrs
State
UT
Recovered
Unknown
Vaccinated
Jan 5, 2026
Onset
Jan 5, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS347XP4—

Symptoms (1)

Underdose

Symptom narrative

an adult patient received a pediatric dose; an adult patient received a pediatric dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 28-year-old female patient who received HBV (Engerix B pediatric) (batch number 47XP4) for prophylaxis. On 05-JAN-2026, the patient received the 3rd dose of Engerix B pediatric. On 05-JAN-2026, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: an adult patient received a pediatric dose) and underdose (Verbatim: an adult patient received a pediatric dose). The outcome of the adult use of a child product and underdose were not applicable. Additional Information: GSK receipt date: 07-JAN-2025 The reporter consented to follow up. The vaccine administration facility was the same as primary reporter. The batch number was not provided upon follow- up with the reporter.